A Patient-Caregiver Behavioral Intervention (COPE+) for the Support of Cancer Patients with Mild Cognitive Impairment
This clinical trial tests the effect of COPing TogEther and Living Well Program + Communication (COPE+) on the experiences of cancer patients with mild cognitive impairment (MCI) and their caregivers. Older adults living with cancer and MCI run a serious risk of being functionally and psychologically disadvantaged. MCI is characterized by symptoms of increased forgetfulness, difficulty concentrating and decreased work or household performance. Patients with MCI have a higher risk for distress and are more likely to require assistance with daily functions and management of symptoms of cancer and side effects of treatments. Caregivers of patients with MCI are often responsible for medical decisions and ensuring patients are compliant with treatment. Caregivers of cancer patients with MCI have an added layer of uncertainty and vigilance to determine the needs of the patient at any given time. Patients and caregivers may benefit from a system of support. COPE+ is a behavioral support intervention that uses videoconferencing. Behavioral interventions use techniques to help patients and caregivers change the way they react to environmental triggers that may cause a negative reaction. COPE+ may reduce distress and improve the well-being and quality of life of patients and their caregivers.